The new device attaches to organs using proteins found in the feet of mussels Patients take a drug that leaves their tumors vulnerable to the effects of light The device, created by Japanese experts, then emits light to tackle the cancer Early trials on mice proved the form of photodynamic therapy to be effective A...
Category: <span>Research Updates</span>
Strong sensitivity to bitter tastes tied to higher cancer risk
New research suggests that a raised sensitivity to bitter tastes might be a good predictor of cancer risk in women. Researchers are investigating the mysterious link between sensitivity to bitter tastes and the risk of cancer in women. A recent study has started to investigate the link between sensitivity to better tastes and the risk of cancer. It...
The roles of RNA-RNA interactions
July 20, 2018, Ludwig Maximilian University of Munich Chronic regeneration of damaged endothelial cells at sites of disturbed blood flow in the vasculature promotes the development of atherosclerosis. Now an LMU team has further elucidated the role of a short RNA molecule in atherogenesis. Credit: Design-Cells / fotolia.com Atherosclerosis – the condition is popularly known as hardening...
Treating dementia with the healing waves of sound
Ultrasound applied to the brain could help treat patients with dementia. TOHOKU UNIVERSITY Ultrasound waves applied to the whole brain improve cognitive dysfunction in mice with conditions simulating vascular dementia and Alzheimer’s disease. The research, conducted by scientists at Tohoku University in Japan, suggests that this type of therapy may also benefit humans. IMAGE: ULTRASOUND TREATMENTS COULD...
Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model
A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM, Ala. – Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed? IMAGE: THE MOUSE IN THE CENTER PHOTO SHOWS AGING-ASSOCIATED SKIN WRINKLES AND HAIR LOSS...
Wearable device from Stanford measures cortisol in sweat
STANFORD UNIVERSITY The hormone cortisol rises and falls naturally throughout the day and can spike in response to stress, but current methods for measuring cortisol levels require waiting several days for results from a lab. By the time a person learns the results of a cortisol test – which may inform treatment for certain medical...
Aggressive immune cells aggravate Parkinson’s disease
July 20, 2018, University of Erlangen-Nuremberg Parkinson’s disease, formerly referred to as “shaking palsy,” is one of the most common disorders affecting movement and the nervous system. Medical researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have reported a possible cause of the disease in the immune system. The scientists have published their research findings in the journal Cell Stem Cell. Immunohistochemistry for alpha-synuclein...
Microscopic, Remotely Powered Implant to Read, Transmit Brainwaves from Inside Skull
Brain-computer interfaces and other technologies that rely on reading and stimulating the brain require electrodes to obtain and deliver signals, as well as a way to transmit those signals from within the brain. Electric wires have usually served as the method of connectivity, but they create serious challenges, including a potential for infection, safety issues,...
Targeting headaches and tumors with nano-submarines
New method of transporting drugs published in Nature Nanotechnology JOHANNES GUTENBERG UNIVERSITAET MAINZ Scientists at the Mainz University Medical Center and the Max Planck Institute for Polymer Research (MPI-P) have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may...
Drug now in clinical trials for Parkinson’s strengthens heart contractions in animals
JOHNS HOPKINS MEDICINE A drug currently in clinical trials for treating symptoms of Parkinson’s disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers. The drug, a member of a class of compounds known as phosphodiesterase (PDE) type I inhibitors, shows promising effects on...